Insider Sale at Eli Lilly (LLY) Continues Selling Trend

Monday, October 02, 2017 10:15 PM ET

Insider Sale at Eli Lilly (LLY) Continues Selling Trend

An insider sold 195,000 shares of Eli Lilly having a market value of approximately $16,602,601 today, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 590,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 785,000 shares and have averaged 392,500 shares per transaction over this time period.

Relative to its peers over the last 90 days, insider buy/sell trading at Eli Lilly is greater than the 115-company peer group average. Pharmaceuticals peer group saw 116 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Eli Lilly insiders was also higher. Within the peer group there were 3,190,903 shares purchased and 4,956,667 shares sold with company insiders having sold 15,222 shares on average.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to create and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.